Alkermes: Lilly to end inhaled insulin deal
March 07 2008
Biotech firm Alkermes said today it expects Eli Lilly to soon back out of its inhaled insulin development deal between ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.